Funding Resources - Full list

Research Authority - Technion R&D Foundation

Active Funding Resources in Medicine and Life Sciences

[All funds | Life | Exact and Materials | Social & Humanities]

For assistance call Robi – 2152 robertg@technion.ac.il, Iris – 1272 irisbr@trdf.technion.ac.il, Luba – 1477 lubak@technion.ac.il

The list is arranged by deadlines chronological order (dd.mm), first Israeli divided by RFPs and Workshops, then Foreign

Deadlines are highlighted in Green

Please note:
1) No overhead implies that overhead costs to the academic institute are not covered by the grant.
2) Overhead XX% implies that overhead costs to the academic institute are covered partially.

Please contact Research Authority if planning to submit.

Israeli:

16.4 | Era-Net (MOH): THCS- Transforming Health and Care Systems – Healthcare of the Future

(Obligatory "Intent to apply” deadline)

Submission deadline for proposals: 14 May 2024

Webinar on March 12th from 16.00 – 17.30 CET. click here to register.

Consortia of minimum 3 partners from 3 eligible countries

aiming to encourage the optimization of patient care pathways and contribute to the transition towards more sustainable, efficient, resilient, ethical, high-quality, and accessible person-centered healthcare systems.

Funding for the Israeli partner: €140K over 3 years (€180K for coordination).

* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre

proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272,1477).

https://www.thcspartnership.eu/funding/pre-announcement-of-the-second-joint-transnational-call.kl

Call text

1.5 | Bar-Ilan University Press: President's Prize

הוצאת הספרים של אוניברסיטת בר-אילן: פרס נשיא אוניברסיטת בר־אילן לספר המחקר הטוב ביותר לשנת תשפ"ד יוענק לחיבור מקורי של ספר מחקר ועיון שנכתב בעברית ויוגש להוצאת הספרים של אוניברסיטת בר-אילן. מטרת הפרס היא להוקיר ולעודד כתיבה מחקרית מעולה הפונה גם לציבור המשכיל הרחב.

סכום הפרס: 30,000 ₪ למקום הראשון ו- 10,000 ₪ למקום השני.

לתקנון הפרס

1.5 | US-Israel Binational Agricultural Research and Development Fund (BARD)/ NIFA-BARD-MOST: Nutritional Security (Pre-application)

The nutritional Security program is a new funding track that enhances U.S.-Israel collaboration on joint scientific innovation to address the multifaceted challenges of nutritional security. The program focuses on solutions to promote health, reduce hunger and address diet-related health issues while enhancing sustainability. Beyond food quality, the program places specific emphasis on the affordability, accessibility, and overall availability of nutritionally balanced diets that are crucial for human well-being.

Priority areas:
*Impact of nutrition and diet on health and well-being
*Food Science, processing and safety
*Sustainable solutions for nutritional security

Funding: Up to 480,000 NIS for 3 years.

Collaboration is limited to American research scientists who have been funded by NIFA (the list of projects).

https://www.bard-isus.com/fundingTypes/Details/24

10.5 | American Cancer Society: Yosemite Award - AI and/or immuno-oncology

Supports innovative research to develop methodologies, establish feasibility, or pilot high risk/high reward projects to advance the prevention, diagnosis, or treatment of cancer.

Funding: up to $300K for 1 or 2 years

https://www.ra.trdf.co.il/files/ACS Yosemite Grant Program.pdf

15.5 | Ministry of Health and Naomi Foundation: Kadar-Sheba Prize for Excellence in Research

Inspired to promote and accelerate excellence in biomedical research, the Naomi Foundation has decided to celebrate the scientific achievements of a leading physician-scientist within all Israeli medical centers. Award of $100,000 to a single recipient, with $75,000 dedicated to supporting research and $25,000 as a personal award to the recipient.

https://www.ra.trdf.co.il/files/Kadar_Sheba_2024.pdf

15.5 | VATAT – MOST ‘Proof of Concept’ Research Projects

ות"ת-משרד המדע: תכנית למימון מחקרי הוכחת היתכנות

הוועדה לתכנון ותקצוב (ות"ת) ומשרד משרד המדע מעוניינים לתמוך במשותף בביצוע הוכחת היתכנות למחקר מדעי ואקדמי בעל פוטנציאל ליישום מסחרי.

קול קורא זה בא לתמוך במחקר בשלב הוכחת היתכנות בלבד (POC: Proof of Concept)

כלומר, מחקר בו אין גוף מסחרי המעוניין להשקיע (מפאת רמת הבשלות הטכנולוגית).

יודגש כי הקול הקורא פתוח לכל תחומי הדעת האקדמיים, אך הצעת המחקר נדרשת להיות בעלת פוטנציאל יישומי ברור (תעשייתי, ציבורי או חברתי).

גובה ומשך המענק - עד 350,000 ₪ לתקופה של 18-24 חודשים.

הצעות המחקר יכולות לכלול שותפים מהטכניון או ממוסדות אקדמיים אחרים.

הטכניון רשאי להגיש 10 הצעות מטעמו, על כן יערך תהליך בחירה פנימי שינוהל בלשכת המנל"מ.

חוקרים המעוניינים להגיש הצעה, מתבקשים לשלוח הצעה מלאה, באנגלית, עד 15.5 לכתובת: ra-tec@technion.ac.il

מבנה ההצעה:

^ ההצעה תוגש באנגלית על גבי הטפסים שבקישור למטה

* עמוד שער: כותרת, שמות החוקרים מגישי ההצעה, מחלקה ופרטי קשר (אין טופס מיוחד).

* תכנית המחקר: (עד 5 עמודים, לא כולל מקורות)

* תקציב (עד עמוד אחד)

* נספח ישימות (עד 2 עמודים(

* קורות חיים, כולל רשימת פרסומים רלוונטיים (עד 2 עמודים לכל חוקר)

חוקרים שהצעתם תאושר בתהליך הבחירה המוסדית, יוכלו לערוך ולעדכן את הצעתם עד למועד ההגשה למממן – 18.6.24.

בקישור הבא מופיע נוסח עדכני של הקול הקורא, טופסי הגשה (ישמשו גם להגשה הפנימית בטכניון) וכן סיכום של מפגש מתעניינים שנערך לאחרונה:

www.gov.il/he/departments/publications/Call_for_bids/rfp02042024

19.5/30.8 | Tokushima University – Technion Collaboration (3rd round) - any scientific topic of mutual interest

Following a Memorandum of Understanding between the Nichia Corporation, Tokushima University and the Technion, Nichia Corporation intends to fund up to 5 joint research projects of researchers from TU and the Technion.

Research domains: any scientific topic of mutual interest.

Funding: Projects are planned for two years with a total funding of $100K/year/project ($50K/year/PI).

Application procedure:

Stage 1 - An optional initial one-page pre-proposal + one-page CV will be submitted by email to TISI Office - tisi_office@tokushima-u.ac.jp or to Technion Research Authority - ra-tec@trdf.technion.ac.il by May 31.

This stage is optional and meant to help Technion PIs in finding a suitable partner at Tokushima University and vice-versa, therefore, there is no requirement for a partner from the other institution. The pre-proposals will serve only to identify possible TU/Technion collaborators (but not for any kind of pre-selection).

The pre-proposals submitted at each university will be disclosed to the researchers from the other university to allow a matching process.

Both universities' PIs will actively contact each other based on their Keywords, Research Fields, and Topics to form international research groups.

Stage 2 - Successfully matched PIs jointly prepare a collaborative research proposal and submit it from Tokushima University's PI to TISI office - tisi_office@tokushima-u.ac.jp. by August 30.

One PI can apply with two collaborative proposals.

The Project Guidance Team will notify the results in November 2024.

Call for Proposals, forms and Application Guidelines: www.acot.tokushima-u.ac.jp/Information/call-for-tisi-collaborative-research-project-phase-3/

Tokushima Researcher’s information:

* Educators and Researcher’s Directory: http://pub2.db.tokushima-u.ac.jp/ERD/organization/10992/index-en.html

* Names and Research Fields: www.isc.tokushima-u.ac.jp/english/app/wp-content/uploads/2024/02/faculty-research-interests.pdf

* Video Messages: www.acot.tokushima-u.ac.jp/ourcontents/audio-visual

1.6 | Israel Institute for Advanced Studies (IIAS): Michael Bruno Award for Israeli Scholars in STEM Fields

The Michael Bruno Memorial Award is granted annually to three outstanding mid-career Israeli scholars who have demonstrated an exceptional originality of mind, dedication and ground-breaking impact in their research, and who have succeeded in influencing and re-shaping their field of expertise. This award, a personal prize in the amount of 200,000 NIS, is both the highest recognition of past accomplishments and a vote of confidence in the laureates’ future achievements and contributions to research and Israeli academia.

Eligible candidates must be faculty members of STEM fields in Israeli research institutions who are under 50 years of age as of February 15, 2024 or up to 15 years after first University appointment.

https://www.ra.trdf.co.il/files/BrunoOpenCall.pdf

17.6 | Israel National Institute for Health Policy and Health Services Research (NIHP): pre-proposals

המכון הלאומי לחקר שרותי הבריאות ומדיניות הבריאות: הצעות מקדמיות

תחומים: מדיניות בריאות, ארגון שרותי הבריאות, כלכלת בריאות, איכות שרותי הבריאות

השנה תינתן עדיפות לנושאים:

1. מערך השיקום הפיזי בישראל

2. עיצוב ופיתוח תחום בריאות הנפש

3. צמצום פערי בריאות בין מרכז לפריפריה

בנושאים אלה תינתן עדיפות למחקרים בעלי פוטנציאל למדיניות בת יישום ולתוכניות מעשיות שניתן לאמצן.

מימון: מחקר רגיל: עד 150,000 ₪ לשנה וחצי.

מחקר מקיף עד 300,000 ₪ לשנתיים עד שלוש שנים.

https://www.israelhpr.org.il/research-grants/

1.12 | Israel Institute for Advanced Studies (IIAS): 2026-2027 Individual Fellowships and Research Groups (all disciplines)

Individual Fellowships: scholars from Israel and abroad are invited to submit proposals for residencies (5 or 10 months) at the IIAS. Proposals must seek to be innovative, with the potential to impact research in the field. Two or three scholars who collaborate on the same project should apply individually and state clearly that they wish to work together.

https://iias.huji.ac.il/Individual_researchers

https://www.ra.trdf.co.il/files/IF.pdf

Research Groups: scholars from Israel and abroad (5-8 core fellows) invited to submit proposals (which must seek to be innovative with potential impact on their research field) to spend residency (3, 5, 10 months) at IIAS.

https://iias.huji.ac.il/RG_Application

https://www.ra.trdf.co.il/files/RG.pdf

https://iias.huji.ac.il/open-calls

NSF-BSF programs:

Israeli researchers can join research proposals submitted by US PI(s) to the NSF, in the programs listed below. Two applications per calendar year (Oct 1 – Sept 30) are permitted

The Israeli budget is funded by the BSF as follows: up to $80K/yr for experimental studies and $55K/yr for theoretical and computer-based studies.

Pay attention to the application deadlines. While many programs are open all year long, some still have specific time limits.

Details on all NSF-BSF programs: www.bsf.org.il/funding-opportunities/nsf-bsf-joint-research-grants/the-programs/

· Biocomputing through EnGINeering Organoid Intelligence (BEGIN OI): Jan. 17

· Economics and Decision Sciences: Jan. 24

· Computing and Communication Foundations (CCF): Open All Year

· Computer Networks and Systems (CNS): Open All Year

· Information and Intelligence Systems (IIS): Open All Year

· Cyber Security and Privacy (SaTC): Open All Year - In any case, Israeli PIs will consult with Ms. Yael Dressler in the BSF office (yael@bsf.org.il) regarding their project description and budget request before advancing the preparation and submission of their proposal.

· Foundational Research in Robotics: Open All Year

· Physics: Various Deadlines

· Materials (DMR): Open All Year

· Astronomy and Astrophysics: Nov. 15

· Mathematics: Various Deadlines

· Mathematical and Scientific Foundations of Deep Learning: Various Deadlines

· Electrical, Communications and Cyber Systems (ECCS): Open All Year

· Chemical, Bioengineering, Environmental and Transport Systems (CBET): Open All Year

· Civil, Mechanical and Manufacturing Innovation (CMMI): Open All Year

· Earth Sciences (GEO): Open All Year

· Atmospheric and Geospace Sci.: Open All Year

· Marine Oceanography: Various Deadlines

· EAGER (Early-Concept applications in all the active NSF-BSF programs): Open All Year

· Chemistry: Various Deadlines

Israeli - all year round:

DFG – German Science Foundation: Research Grant for Middle East Collaboration

Researchers working in Germany who meet the DFG’s eligibility requirements can submit a joint proposal to fund domestic (German) and international project costs with colleagues from:

· Israel (bilateral projects) or

· Israel and Palestine or the following countries that neighbour Israel: Egypt, Jordan, Lebanon and Syria (trilateral or multilateral projects).

· Funding levels are typically ~ €300K over 3 years for all partners.

www.dfg.de/en/research_funding/programmes/international_cooperation/middle_east_collaboration

www.dfg.de/formulare/54_016/index.jsp

ICL (Israeli Chemicals Ltd): ICL Open Innovation (Crop Nutrition and Applied Agronomy)

ICL is looking to fund research projects in the following domains:

Crop Nutrition:

· Enhanced Efficiency Fertilizers

· Biostimulants

· Biodegradable CRF Coating

· Nitrogen Fixation

· Organic Fertilizers

· Secondary nutrients

· Delivery Platform

· Ammonia synthesis

· Increased P-availability

Applied Agronomy

· Efficient fertilizers application

· Regenerative Agriculture practical methods

· Water use efficiency practical methods

· Nutrient balance (plant, soil, water, atmosphere) sensing/analysis

· GHG emissions sensing/analysis

· Soil microbiome sensing/analysis

· Soil/groundwater contamination sensing/analysis

· Yield estimation by remote sensing

· Plant nutrition’s DSS

Funding: The budget for the selected proposals will be negotiated with ICL

For further details, please contact Adi Perelman Adi.Perelman@icl-group.com

https://www.ra.trdf.co.il/files/ICL Open Innovation .pdf

Israel Insurance Association Research Fund: Research Grants on Natural Hazards

The Fund welcomes applications for financial support for the purpose of conducting research on insurance matters, especially on the subject of motor bodily injury insurance, and other insurance branches of importance to the public interest (i.e Earthquake and other Natural hazards risks and insurance). Funding: ask the Research Authority - 2152

Eng: www.igudbit.org.il/eng/Index.asp?CategoryID=451

Heb: www.igudbit.org.il/Index.asp?CategoryID=420

Guidelines and form: www.igudbit.org.il/_Uploads/1616keren(1).doc

The Israel Securities Authority (ISA) (HA'RASHUT LE'NIAROT ERECH): Research Grants

Research grants in amount of 5,000-40,000 NIS in subjects relevant to ISA activity.

http://www.isa.gov.il/GeneralResearch/179/Pages/default.aspx

Shaare Zedek Medical Center: Corona samples

המרכז הרפואי שערי צדק: קול קורא לשימוש בדגימות קורונה

דגימות ביולוגית מחולי SARS-CoV-2 ומקבוצת ביקורת, לרבות סרום, פלזמה, דם מלא, ומטושים, כולל כל המידע הקליני הקשור לדגימות אלו. על המחקרים לסייע בקידום הידע בתחום זה, ולעודד קידום שיתופי הפעולה עם המרכז הרפואי.

רשאים להגיש חוקרים או חברות בארץ ובחו"ל, ובלבד שיהיה שותף משערי צדק. במידה ואין שותף, ניתן לבקש חיבור שותף מתאים.

- הדוגמאות, הליווי הקליני, וקבלת אישורים רגולטוריים למחקר ניתנות ללא עלות וממומנות על ידי על ידי הרשות למחקר ופיתוח ע"ש איזנברג במרכז הרפואי שערי צדק.

אנא צרו עימנו קשר במידה ובכוונתכם להגיש הצעה. הצעות מחקר יש לשלוח ל: research@szmc.org.il על גבי הטופס בקישור. תשובה ראשונית תינתן בתוך 14 יום. למידע נוסף, ניתן לפנות למיכל גרשוני, רכזת מענקי מחקר: michalge@szmc.org.il

https://www.ra.trdf.co.il/files/Corona samples call.jpg

Foreign:

14.4 | Pfizer: Independent Research Grants

Investigator-Sponsored Research (ISR): An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or nonfinancial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset.

General Research: general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset.

Funding: not specified.

https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research

14.4 | Josef Steiner Cancer Research Foundation Award 2025

Supports early career investigator (typically 40 years or less (Involved in projects in basic and/or clinical cancer research (specifically, the translation of new basic/theoretical insights into clinical applications) and Able to provide the infrastructure needed to carry out the proposed project.

Funding: up to CHF 1M over 4 years and a personal prize of CHF 50'000.

https://www.steinerstiftung.unibe.ch/guidelines.aspx

15.4 | Angelman Syndrome Foundation

Priority will be given to the following topics:

- Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.

- Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.

- Projects studying delivery of therapies and potential for improvement.

- Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.

Proposals that do not address these topics are still welcome and will be given full consideration.

Funding: $100K per year for 1 or two years

https://www.angelman.org/as-research/call-for-proposals

15.4 | The Prostate Cancer Foundation (PCF): Young Investigator Awards

Encourage young investigators working on prostate cancer health disparities

Funding: $75K per year for 3 years (no overhead)

https://www.pcf.org/science-impact/for-researchers/open-rfas/

https://www.ra.trdf.co.il/files/RFA_2024-Young-Investigator-Award_1.23.24.pdf

16.4 | American Association for Cancer Research (AACR): Cancer Disparities Research Fellowship

Encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to cancer disparities. Work under the auspices of a mentor.

Funding: $130K for 2 years (no overhead)

https://www.aacr.org/grants/aacr-cancer-disparities-research-fellowship/

16.4 | Wellcome Trust: Discovery Awards

provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health, and wellbeing.

Funding: the average size of a Discovery Award is £3.5 million, although the trust have supported awards from £700,000 to £8 million.

Please note: the host organisation of the lead applicant needs to be based in UK, Republic of Ireland, Low- or middle-income countries

https://wellcome.org/grant-funding/schemes/discovery-awards

17.4 | Preeclampsia Foundation: Vision Grant 2024

Initial funding for young investigators (within 10 years from PhD) to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome;

Funding: up to $20K. The Foundation’s affiliate, Preeclampsia Foundation Canada, will award one Vision Grant up to $25K CAD to study HELLP Syndrome.

www.preeclampsia.org/research-funding

18.4 | The Peanut Institute: Peanut Nutrition Grants

General Research Grant

Enhance our understanding of how consuming peanuts, peanut butter, and peanut products affects health in various populations.

Funding: $25K-$250K for 1 year

https://www.ra.trdf.co.il/files/General grant.pdf

Public Health Research Grant

Effect of consumption of peanuts/peanut products in the diet on human health, and for reducing the public health burden of chronic diseases. Specifically, robust designs, including large scale and/or long-term human studies. The main PI should be based in the US.

Funding: $350K - $650K for multi-year projects

https://www.ra.trdf.co.il/files/Public Health Call.pdf

https://peanut-institute.com/research-resources/peanut-nutrition-grant/

18.4 | Pfizer: Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL)

Producing Bacterial Infections

Foster healthcare professional education to support them in making evidence-informed decisions in

the diagnosis and management of patients with Metallo-β-Lactamase(MBL) producing bacterial infections.

Funding: up to $100K

https://www.ra.trdf.co.il/files/Producing Bacterial Infections IME.pdf

18.4 | The Gateway for Cancer Research

Seek to bring urgency to the process of cancer research for patients who are looking for treatments today and are faced with difficult decisions without innovative, life-saving options. Gateway will place increasing emphasis on funding patient-centered and novel research.

Gateway Traditional Grant Program

Core grants funding early phase clinical trials for cancers of all types

Funding: from $200K to $1.5M for 2-5 years

Integrative Research

Funding integrative oncology research that pairs conventional therapies with evidence-based, complementary therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life during treatment.

Society for Integrative Oncology (SIO)

Support integrative clinical trials conducted by principal investigators and institutions among its membership. SIO’s mission is to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.

Decentralized Clinical Trial Initiative (DCTI)

Fund research leveraging site-less, technology-informed trials, with the objective of bringing clinical trials directly to patients’ doorsteps.

https://gatewaycr.smapply.org/prog/gfcr_all_grant_programs_-_v122023/

19.4 | Alternatives Research & Development Foundation (ARDF): Annual open grant program

Promote the development, validation, and adoption of non-animal methods in biomedical research, product testing, and education.

Proposal evaluation is based on scientific merit, feasibility, and the potential to reduce or replace the use of animals in the near future.

Funding: max $40K

https://www.ardf-online.org/ardf-grants.html

22.4 | Defeat Duchenne Canada: Research Grants - competitive LOI

Focused on treating and improving the lives of individuals living with Duchenne muscular dystrophy. Successful proposals are expected to be of high scientific merit, demonstrate a clear, probable, and timely path toward clinical implementation. Priority - most significant impact on boys and young men living with Duchenne.

Funding: no maximal limit for 1-3 years

https://www.ra.trdf.co.il/files/Criteria-FINAL.pdf

https://defeatduchenne.ca/granting-process/

23.4 | Cystic Fibrosis Foundation: Health Equity Team Science Award - LOI

Research projects should have the potential to improve our understanding of or have a positive impact on identified barriers to optimal health outcomes for all people with CF related to race and ethnicity, sexual orientation or gender, or socioeconomic status.

At least two but no more than four investigators may be included on a given project. Co-investigators may be at the same or different institutions.

Applicants must speak with program staff prior to submission to ensure the project design is in line with the goals of this request for application.

Funding: up to $200K per year for up to 4 years

https://www.cff.org/researchers/health-equity-team-science-award

https://www.ra.trdf.co.il/files/Health Equity Team Science Award.pdf

23.4 | VELUX STIFTUNG

Daylight Research

Highly interdisciplinary, on the effects and utilization of daylight in three fields:

- Daylight and humans

- Daylight and nature

- Daylight technology

Healthy Aging

Bio-psycho-social approach and support research that aims to sustain or increase the functional ability and intrinsic capacity of older people.

Funding: CHF 50-70K ($57-114K) per year for 1-4 years (possible to exceed with pre-approval)

https://veluxstiftung.ch/funding-areas/daylight-research/

https://veluxstiftung.ch/funding-areas/healthy-ageing/

29.4 | LUPUS Research Alliance: Translational Bridge Award - competitive LO'Is

Milestone-driven projects with strong, relatively near-term commercialization potential or with an immediate opportunity for clinical evaluation. All projects should advance the discovery of potential commercial entities or clinical products with a clear and direct relevance to people with lupus and offer the potential to improve diagnosis or standard of care for the disease or usher in a cure.

Funding: up to $450K over 2 years

https://www.ra.trdf.co.il/files/2024-TBA-RFA.pdf

https://www.lupusresearch.org/for-researchers/funding-opportunities/

30.4 | The Louis Bachelier Network: ReFinE Call for Projects

To promote and enrich scientific research on the links between real estate and finance, considering the physical nature of assets.

physical nature of assets (location and geographical diversification, fixed costs, irreversibility). Open to all academic disciplines.

Priority themes:

- Climate and real estate issues

- The liquidity of open-ended real estate funds

- Land development and value enhancement

- Differentiated effects of land artificialization depending on the type of construction

- City centers, suburbs, and commercial real estate

- Evaluating macroprudential policies in residential real estate

- Public policy, incentives, and energy transition

- Design of property and real estate taxation (local tax competition) and national taxation (IFI and ISF)

Funding: up to 4,000 EUR, seminars and conferences organized by the Institute as part of the network.

https://www.institutlouisbachelier.org/en/calls/current-calls/

https://docs.google.com/forms/d/e/1FAIpQLSfcugYeZVHNsgDD4jWmLp8SoDXwssfZftViB_KpQhxqIIfUdw/viewform

30.4 | The Morton Cure Paralysis Fund (MCPF): Research Grants

(another deadline on Oct. 31)

Funds activities that hold promise of identifying therapies (cures) for paralysis in humans. Has particular focus of placing projects in the research pipeline, that is, enabling scientists to develop the proof concept data necessary to apply for larger NIH grants. The development of effective therapies for chronic injury is a high priority for the organization. Basic research will be supported if it has clear potential to accelerate progress at the applied end of the continuum and/or if it reflects innovative research or a ‘change of direction’.

Funding: $5K to $75K for 1 year (second year considered, no overhead)

https://www.ra.trdf.co.il/files/MCPF-Research-Guidelines-2023.doc

https://mcpf.org/new-investigator-grant-application/

30.4 | Thermo Fisher Scientific: Oncomine Clinical Research Grant - Molecular Profiling in Oncology

Investigator-initiated studies and education projects, on molecular profiling in oncology, with the goal to increase high quality molecular profiling and to help democratize the future of precision medicine.

Proposals addressing unmet diagnostic needs using next-generation sequencing for both solid and hematological cancers.

Funding: up to $200K

www.oncomine.com/grants

30.4 | Grifols - LOIs

Albus Award

Focused on innovative ideas related to albumin and its role as a therapeutic product.

https://www.albus-awards.com/en/home

GATRA award

Foster a scientific network and the knowledge in the use of Antithrombin as a therapeutic product

Funding: €50,000 per 1 year

Proposals may include, but are not limited to: efficacy, mechanism of action, safety and tolerability, quality of life and pharmacoeconomics.

https://www.gatra-awards.com/en/home

30.4 | The UK Defense and Security Accelerator (DASA): Sample Preservation, Analysis, And Attribution (SPAA)

This competition seeks proposals for innovations that could help the successful identification of chemical and biological (ChemBio) materials and/or bring perpetrators to justice.

The challenges outlined in this competition are diverse in nature, therefore it is anticipated that proposals will address a certain area rather than covering multiple requirements.

There are three main challenge areas where innovative solutions and approaches are being sought:

· Challenge 1: New screening technologies for rapidly detecting or identifying the presence or class of hazardous ChemBio materials in a sample

· Challenge 2: New sample collection/preservation systems that better maintain the integrity and viability of hazardous samples

· Challenge 3: New analytical approaches to improve the forensic exploitation and the attribution of ChemBio materials and/or recovered chemical/biological weapons material (RC/BWM)

Up to £1 million is available to fund multiple innovations at Technology Readiness level (TRL) 2-4 to deliver fieldable prototypes/software (TRL6+) to support investigations into ChemBio incidents.

https://www.gov.uk/government/news/sample-preservation-analysis-and-attribution-spaa

30.4 | Wellcome Trust: Bioimaging Technology Development Awards

This award will fund teams of technology developers and users to create novel bioimaging tools at the cell-tissue scale. Successful teams will develop technologies that answer ambitious research questions or that overcome barriers to bioimaging work in low-resource settings. Awarded teams will develop tools and technologies to overcome barriers to progress in bioimaging. Specifically, they will advance technologies to investigate biological phenomena at the cell-tissue scale.

Funding:
Foundation phase: up to £500k; Scale-up phase: you should ask for the resources you need for your program.

Duration of funding: Up to 8 years, spanning two phases: a foundation phase for the first 18 months, followed by a scale-up phase up to a maximum of 6.5 additional

years.

Requires UK PI

https://wellcome.org/grant-funding/schemes/bioimaging-technology-development-awards

1.5 | Environmental Research & Education Foundation - Pre-proposals

Topic areas:

Waste minimization, Recycling, Waste conversion to energy, biofuels, chemicals, or other useful products. This includes, but is not limited to, the following technologies:

Waste-to-energy, Anaerobic digestion, Composting. Other thermal or biological conversion technologies, Strategies to promote diversion to higher and better uses (e.g. organics diversion, market analysis, optimized material management, logistics, etc.), Landfilling.

Funding: average of $160K for about 2 years

https://erefdn.org/research-grants-projects/how-to-apply-for-grant/

1.5 | National Center for Responsible Gaming (NCRG): Seed Grant (LOI)

Seed Grants can be used to explore the etiology, prevention and treatment of gambling disorders, and the development and evaluation of responsible gambling strategies.

Funding: up to $40,000 per year per year in direct costs and up to 15% indirect costs for 1 year .

https://www.icrg.org/information/apply-for-icrg-funding

2.5 | Cystic Fibrosis Foundation

Pilot and Feasibility Awards

Intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.

Funding: $50K per year for up to 2 years

https://www.ra.trdf.co.il/files/Pilot-and-Feasibility-Awards.pdf

https://www.cff.org/researchers/pilot-and-feasibility-awards

Path to a Cure Pilot and Feasibility Awards

Supports research that will accelerate the discovery and development of therapies to restore cystic fibrosis transmembrane conductance regulator (CFTR) function in all patients with cystic fibrosis.

Funding: $50,000 per year for up to 2 years

https://www.ra.trdf.co.il/files/PTAC-Pilot-and-Feasibility-Award.pdf

https://www.cff.org/researchers/path-cure-academic-programs

Research Grants

To support (non-Path to a Cure related) basic science research that will provide new insights that contribute to the understanding of the basic etiology and pathogenesis of cystic fibrosis.

Funding: $150K per year for up to 3 years

https://www.ra.trdf.co.il/files/Research-Grants.pdf

https://www.cff.org/researchers/research-grants

Path to a Cure Research Grants

To support basic science research that may enable the development of new therapies that directly impact CFTR function.

Funding: $150K per year for up to 3 years

https://www.ra.trdf.co.il/files/PTAC-Research-Grants.pdf

https://www.cff.org/researchers/research-grants

2.5 | The European Foundation for the Study of Diabetes (EFSD) and Sanofi: European Diabetes Research Programme on Autoimmunity in Type 1 Diabetes

To stimulate and accelerate European research aimed at improving understanding of any aspect of autoimmunity in type 1 diabetes, its pathogenesis, screening and monitoring, its clinical course, and its interventions. Grants are offered for basic and clinical studies.

Funding: up to 100K EUR for 1 year or longer (Non-profit)

https://www.europeandiabetesfoundation.org/workshops/132-efsd-and-sanofi-european-diabetes-research-programme-autoimmunity-type-1-diabetes.html

2.5 | European Crohn’s and Colitis Organization (ECCO) - LOIs

Pioneer Award

Encourage and support innovative basic and/or clinical scientific research in the area of Inflammatory Bowel Diseases (IBD) across Europe.

Funding: 300K EUR for 2 years

Global Grant

Extend the outreach and global perspective of IBD research and may focus on aspects of IBD pathogenesis (e.g. environmental impact, genetics), epidemiology and/or clinical care, among others. Applications must be multicenter and address knowledge gaps and/or unmet needs relevant to low and lower-middle income countries and feature strong contributions from these countries. At least one Principal Investigator who is from a low- or lower-middle income country.

Funding: 300K EUR for 2 years

European Crohn´s and Colitis Organisation - ECCO - Fellowships and Grants (ecco-ibd.eu)

2.5 | Juvenile Diabetes Research Foundation (JDRF): Project Concepts (LOI)

Aim: funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research. Funding: The budget and duration of funding are variable and continued funding is based on satisfactory effort and quarterly progress on milestones.

https://grantcenter.jdrf.org/rfa/project-concepts-strategic-research-agreement/

6.5 | Crohn's & Colitis Foundation of America – LOIs

Senior Research Awards

To provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources such as the National Institutes of Health (NIH).

Funding: $130K per year for 1-3 years (10% indirect costs)

https://www.crohnscolitisfoundation.org/research/grants-fellowships/senior-research-awards

Litwin Inflammatory Bowel Disease (IBD) Pioneers

Supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future.

Funding: $130K (clinical trials), $110K (lab-studies) per year for 1-2 years (10% indirect costs)

https://www.crohnscolitisfoundation.org/research/grants-fellowships/litwin-ibd-pioneers

Summer 2024 | Inflammatory Bowel Disease (IBD) Ventures

Discovery or development of a novel product with the potential to help patients.

Funding: up to $500K per year. Funded programs will be offered accelerator resources and advising.

6.5 | DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP)– Pre-Proposals/LOI

Cardiovascular Health: Cardiomyopathy: Computational Biology for Precision Health |

Congenital Heart Disease | Proteomics | Vascular Malformations

Hemorrhage Control and Blood Products: Hemorrhage Control | Proteomics | Trauma

Respiratory Health: Computational Biology for Precision Health | Proteomics | Pulmonary Fibrosis | Respiratory Health

Orthopaedic Medicine: Accelerated Aging Processes Associated with Military Service | Computational Biology for Precision Health | Musculoskeletal Disorders Related to Acute and Chronic Bone Conditions and Injuries | Proteomics

Award Mechanism:

Discovery Award: up to $275K for 2 years

Investigator-Initiated Research Award: Up to $1M over 4 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583103

6.5 | Pfizer and Bristol-Myers Squibb (BMS): Grant program

To enhance understanding of the oral anticoagulant treatment of patients with atrial fibrillation and/or venous thromboembolism. Grant proposals should leverage

innovative data and content delivery mechanisms including an omnichannel approach.

Requests for regional/multi-country educational proposals are within scope, however, single-country programs will not be considered.

Funding: Up to $300K

https://www.ra.trdf.co.il/files/GMG_2024_IM_PfizerBMSCVIME.pdf

10.5 | LifeArc: Motor Neuron Disease Translational Challenge - expression of interest (EOI)

Fund high quality innovative proposals that set out a rigorous evidence-based approach to the preclinical translation of repurposed drug candidates and drug candidate combinations, uniquely including funding for independent replication of project results through LifeArc.

Funding: up to 750K EUR

https://www.lifearc.org/focus-areas/neurodegeneration/motor-neuron-disease-translational-challenge/mnd-drug-repurposing-programme/

13.5 | Male Contraceptive Initiative: Research Projects - competitive LOI's

Support research projects with application in the development of reversible non-hormonal contraceptives delivered to men.

The David Sokal Innovation Awards

Projects in discovery or exploratory phases of contraceptive development, including hit-to-lead optimization.

Funding: up to $200K for 2 years

Development Awards

Projects in early-to-late stages of contraceptive development, including preclinical studies and beyond.

Funding: up to $400K for 2 years

https://www.ra.trdf.co.il/files/mci_2024-100_300_rfa_announcement.pdf

www.malecontraceptive.org/funding.html

13.5 | Alzheimer’s Drug Discovery Foundation (ADDF) – LOIs

* Drug Development: up to $5M.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/drug-development-rfp

* Neuroimaging and CSF Biomarker: $600K for 1 year

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers

* Prevention: up to $5M for clinical trials based on stage and scope of research.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/prevention-pipeline

Please note overhead is not covered.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities

13.5 | DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP)– Pre-Proposals/LOI

Cardiovascular Health: Cardiomyopathy: Computational Biology for Precision Health |

Congenital Heart Disease | Proteomics | Vascular Malformations

Hemorrhage Control and Blood Products: Hemorrhage Control | Proteomics | Trauma

Respiratory Health: Computational Biology for Precision Health | Proteomics | Pulmonary Fibrosis | Respiratory Health

Award Mechanism:

Impact Award: Up to $2.6M over 4 years.

Clinical Trial Award: Funding limit not defined. Duration 4 years.

Lifestyle and Behavioral Health Interventions Research Award: Up to $3M over 4 years

Technology/Therapeutic Development Award: Up to $4M over 4 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583103

14.5 | U.S. DOD/CDMRP: Ovarian Cancer Research Program (OCRP)– Pre-proposals

Investigator-Initiated Research Award: up to $1.2M for 4 years

Ovarian Cancer Academy - Early-Career Investigator Award: up to $725K for 4years

Pilot Award: up to $300K for 2 year

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581101

14.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- Pre-proposals

Breakthrough Award Level 3: up to $5M for 4 years

Breakthrough Award Level 4: up to $15M for 4 years.

Transformative Breast Cancer Consortium Award: up to $25M for 4 years.

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101

15.5 | The Children’s Heart Foundation: Independent Research Awards - Competitive LIO's

Fund research that directly impacts patients living with congenital heart disease, over the course of their lifetime, through advancing the diagnosis, treatment, and prevention of congenital heart defects.

Funding: up to $150K per year for 2 years.

https://www.childrensheartfoundation.org/for-researchers/

15.5 | Osteology Foundation: Applied Research Grant in oral tissue regeneration

A new flagship programme to actively promote translational and clinical research.

Funding: 200K Swiss francs (~$227K)

https://osteology.org/funding-opportunities/applied-research-grants/

https://www.ra.trdf.co.il/files/granting-guidelinesapprg_v1.pdf

15.5 | American Association for Cancer Research (AACR) & Victoria’s Secret Global Fund: Women’s Cancers Career Development Award

Aims to foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers to eliminate cancer health disparities and improve patient outcome

Funding: $$206K for 2 years.

https://www.aacr.org/grants/victorias-secret-global-fund-for-womens-cancers-career-development-award-in-partnership-with-pelotonia-and-aacr/

15.5 | International Rett Syndrome Foundation: Innovation Awards - competitive LOI's

Advance research aimed at investigating the underlying pathology of the disorder and identifying novel therapeutic approaches to treat and cure Rett syndrome.

Funding: Up to $300K for 2 years

https://www.ra.trdf.co.il/files/2024-Innovation-Awards-RFP-LOI.pdf

https://www.rettsyndrome.org/research/for-researchers/research-grants/

16.5 | Parkinson's UK: Non-drug approaches - preproposals

Fund creative, innovative research into non-drug approaches that will play a vital part in helping people living with Parkinson’s manage their daily challenges and take control of life with Parkinson’s. Co-applicants and collaborators may be based at institutions outside the UK or biotech companies.

Funding: up to 200K EUR for up to 24 months

https://www.parkinsons.org.uk/research/grants-non-drug-approaches

16.5 | Michael J. Fox Parkinson Foundation: Parkinson's Disease Therapeutics Pipeline Program (Full proposal)

Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission. Applicants whose pre-proposal is selected for further consideration will be invited to submit a full proposal through one of the four review cycles.

This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.

The Therapeutics Pipeline Program is only open to industry and industry-academia collaborations.

Funding: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs

Duration: 1-2 years for pre-clinical programs, 2-3 years for clinical programs

https://www.michaeljfox.org/grant/parkinsons-disease-therapeutics-pipeline-program?em_cid=mc-a1bHq00000AbgaK

16.5 | American Association for Cancer Research (AACR): Breast Cancer Research Foundation-AACR NextGen Grant for Transformative Cancer Research (LOI)

Aim: support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific Independence.

Applicants must belong to racial or ethnic group(s) that has been shown to be traditionally excluded in the cancer-related sciences workforce.

Funding: $450,000 for 3 years.

https://www.aacr.org/grants/triple-negative-breast-cancer-research-foundation-aacr-nextgen-grants-for-transformative-cancer-research/

16.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- (LOI)

Breakthrough Award Levels 1 and 2: up to $2M for up to 4 years

Transformative Breast Cancer Consortium Development Award: up to $100K for 1 year.

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101

16.5 | U.S. DOD/CDMRP: Autism Research Program (ARP) – Pre-proposals

Career Development Award: up to $550K for 3 years

Clinical Trial Award: up to $2.2M for 4 years

Idea Development Award: up to $550K for 3 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=577102

20.5 | DOD/CDMRP: Spinal Cord Injury Research Program (SCIRP)– Pre-application

Clinical Translation Research Award: up to $1.35M for 3 years

Clinical Trial Award: up to $3.1M for 4 years

Investigator-Initiated Research Award: up to $600K for 3 years

Translational Research Award: up to $1.35M for 3 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583101

22.5 | DOD/CDMRP: Peer Reviewed Alzheimer's Research Program (PRARP)– LOI

Transforming Care Award: up to $1.6M for 4 years

Transforming Diagnosis Award: up to $2 M for 4 years

Transforming Research Award: up to $1M for 3 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583104

23.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- (LOI)

Era of Hope Scholar Award: up to $3.5M for up to 4 years

Clinical Research Extension Award: up to $6M for 4 years.

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101

24.5 | U.S. DOD/CDMRP: Amyotrophic Lateral Sclerosis Research Program (ALSRP)– LOI

Clinical Outcomes and Biomarkers Award: up to $750K for 3 years

Pilot Clinical Trial Award: up to $2M for 4 years

Therapeutic Development Award: up to $1.5M for 3 years

Therapeutic Idea Award: up to $600K for 2 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581102

27.5 | The European Foundation for the Study of Diabetes (EFSD)/Boehringer Ingelheim European Research Programme on "Multi-System Challenges in Diabetes"

"Multi-System Challenges of Diabetes, Obesity and Cardiometabolic Disease” to encourage innovative basic and clinical projects aimed at:

- Advancing current knowledge in the inter-organ crosstalk and related pathophysiology in Diabetes, Obesity and Cardiometabolic Disease

- Assessing the adaptation and impact of guidelines directed medical care in management of diabetes, Obesity and Cardiometabolic Disease

Funding: up to 100K EUR (up to 300K EUR in exceptional cases) for 1 year or longer (Non-profit)

https://www.europeandiabetesfoundation.org/workshops/96-efsdboehringer-ingelheim-european-research-programme-multi-system-challenges-diabetes

28.5 | DOD/CDMRP: Lung Cancer Research Program (LCRP)

Career Development Award: up to $375K for 3 years (LOI)

Concept Award: up to $120K for 1 year (LOI)

Idea Development Award: up to $525K for 3 years (preproposal)

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583102

30.5 | Lundbeck Foundation: LF Ascending Investigators

To support talented and established scientists to further develop their careers through support of research that may result in a better fundamental understanding of the brain and/or improved prevention, diagnosis and treatment of brain and nervous-system diseases.

Foreign-based researchers can be co-applicant and/or collaborators in the proposed project.

Funding: up to DKK 5M ($730K) over 4 years

https://lundbeckfonden.com/uddelinger-priser/ansoegere/apply-grants/lf-ascending-investigators

https://www.ra.trdf.co.il/files/Ascending Investigators.pdf

31.5 | Fritz Thyssen Foundation: Conferences in Medicine and Natural Sciences, Humanities and Social Sciences

(more deadlines in: August 31, November 30)

Clear connection to the German research system (topic, scientist, institute). Interdisciplinary projects welcomed.

Areas of support:

- History, Language & Culture

- State, Economy and Society

- Medicine and the Natural Sciences

15 to 20 speakers, not earlier than 6 months after application submission, not for a staged conference.

https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/

1.6 | Boehringer Ingelheim Foundation: Heinrich Wieland Prize
This 250,000 euros international prize honors outstanding research on biologically active molecules and systems in the fields of chemistry, biochemistry, and physiology as well as their clinical importance.

https://www.heinrich-wieland-prize.de/heinrich-wieland-prize.html

3.6 | U.S. DOD/CDMRP: Ovarian Cancer Research Program (OCRP)– LOI

Clinical Trial Award: up to $2M for 4 years

Clinical Trial Translational Endpoints Research Award: up to $1M for 3 years

Ovarian Cancer Academy – Leadership Award: up to $1.75M for 3 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581101

4.6 | Volkswagen Shiftung: Scoping workshops

Researchers at German universities and research institutions, international co-applicants

For researchers who want to take a step beyond their current activities and think about the future of their field of research.

Funded scoping workshops are held in Hannover at the Xplanatorium Herrenhausen Palace

conference center. Workshops are supported with funds covering personnel as well as non-personnel or travel costs.

https://www.volkswagenstiftung.de/en/funding/funding-offer/scoping-workshops

https://www.ra.trdf.co.il/files/MB_394_e.pdf

5.6 | DOD/CDMRP: Epilepsy Research Program (ERP)– LOI

Idea Development Award: up to $650K for 3 years

Leveraging Research Award: up to $500K for 3 years

Research Partnership Award: up to $1.2M for 3 years

Virtual Post-Traumatic Epilepsy Research Center - Faculty Award: up to $525K for 3 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=563101

11.6 | CURE Epilepsy: Catalyst Award - LOIs

Supports nimble development of data necessary to advance ideas toward larger commercialization funding opportunities.

Above the level of Assistant Professor.

Funding: $250K for 2 years (no overhead)

https://www.ra.trdf.co.il/files/2023-CURE-Epilepsy-Catalyst-Award-Guidelines_Final_52323.pdf

https://www.cureepilepsy.org/grants-program/

13.6 | Simons Foundation (SFARI): Pilot Award in ASD (autism spectrum disorder)

Intended to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. Investigators new to the field of autism are encouraged to apply for these awards.

Funding: up to $300K for 2 years.

www.sfari.org/grant/pilot-awards-request-for-applications/

15.6 | The LAM Foundation: In-cycle Grant Opportunities - Competitive LOIs

Pilot and Feasibility Grant

To encourage the development and testing of new hypotheses and/or new methods in research areas relevant to LAM (Lymphangioleiomyomatosis).

Funding: up to $50K for up to 1 year

Established Investigator Research Grant

Encourage the development of new information that contributes to LAM Research Priorities. All proposals must be hypothesis generating or hypothesis testing and provide sufficient preliminary data to justify The LAM Foundation’s support.

Funding: up to $150K for up to 3 years

https://www.thelamfoundation.org/investigators/funding-opportunities/

15.6 | GenScript Life Science: Research Grant Program

Supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

Funding: $100K for up to 12 months

https://www.genscript.com/grantprogram.html

https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf

15.6 | Ulverscroft Foundation: Grants for visually impaired people

Supports projects which will have a positive effect on the quality of life of visually impaired people (VI). Funding: not specified.

www.ulverscroft-foundation.org.uk/grants/

20.6 | DARPA: Biological Technologies Office (BTO)– Biological Technologies- abstracts

Abstracts may be submitted on a rolling basis until deadline

BTO is interested in submissions related to the following topic areas:

· General Topics (that fit BTO`s mission)

· Human Performance

· Materials, Sensors, Processing

· Ecosystem and Environmental

· Biosecurity and Biosafety

· Biomedical and Biodefense

Please see BAA for further information.

https://sam.gov/opp/597bf60984314db1b3ecfce393677c75/view

24.6 | CURE Parkinson's: Quarterly Research Grant Funding Programme

(another deadline on 21.10)

Funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

Funding: up to £250K (GBP) and prioritize projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years.

https://cureparkinsons.org.uk/for-researchers/apply-for-funding/quarterly-research-grant-funding/

27.6 | LEO Foundation Award: Region Asia-Pacific

Call opens on May. 16

Advancing the understanding and treatment of skin diseases and strengthening the pipeline of excellent dermatology researchers. It recognizes promising young talents and hopefully provides a boost to their future careers.Criterions: 30-40 years old, scientific merit (5 peer-reviewed publications), active scientist within skin-related research, become a ‘LEO Foundation Alumni’.

Funding: $100K

https://leo-foundation.org/en/grants-and-awards/research-grants / Call guidelines

28.6 | Grifols: GRAIT Awards - LOIs

Annual European and Middle East award to encourage clinicians and researchers to increase insight into immune thrombocytopenia (ITP) or to improve knowledge of the Spleen Tyrosine Kinase (SYK) inhibition as mechanism of action.

Funding: €50,000 per 1.5 years

https://www.grait-awards.com/en/home

30.6 | The Matsumae International Foundation: Research Fellowship

Support program for young researches who want to conduct reseach in Japan

Fellowship period: six months between April 2025 to March 2026.

Fields of research such as natural science, engineering, and medicine are given first priority.

Funding: arrival funding of 120K JPY ($790) and monthly allowence of 220K JPY ($1450)

https://www.ra.trdf.co.il/files/fellowship-announcement-2025_EN.pdf

https://www.mif-japan.org/en/fellowship/announcement/

30.6 | Radala Foundation: Research Grants in ALS

Funds an established, leading PIs pursue a potentially ground-breaking, high-risk project in basic research in ALS.

Funding: 200K CHF (~800,000 NIS) for 2 years (one or two grants will be funded).

www.radala-foundation.com/index.html

1.7 | Ines Mandl Research Foundation (IMRF): Connective Tissue Diseases

IMRF provides research funding in the fight against connective tissue diseases, including, but not limited to emphysema and genetic diseases, especially those related to elastin and elastase concentrating in the causes as opposed to the cure or treatment of the disease. Research may also include the fields of immunology and bio-chemistry.

Funding: Up to $100K over 1-3 years. No overhead.

www.mandlresearch.org/about-1

1.7 | Manpei Suzuki Diabetes Foundation: International Prize for Diabetes Research

For original and excellent achievements in diabetes research that will contribute to the health and welfare of all people.

Funding: $200K and Japanese objet d'art

https://manpeisuzukiprize.org/

16.7 | Thrasher Research Fund: E.W. "Al" Thrasher Awards - Concept papers

Focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics.

Funding: up to $550K for up to 3 years (7% overhead)

https://www.thrasherresearch.org/al-thrasher-award?lang=eng#downloads0

17.7 | DOD/CDMRP: Lung Cancer Research Program (LCRP)- LOI

Patient-Centered Outcomes and Survivorship Award: up to $650K for 3 years.

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583102

18.7 | Michael J. Fox Parkinson Foundation: Parkinson's Disease Therapeutics Pipeline Program (Full proposal)

The Therapeutics Pipeline Program is only open to industry and industry-academia collaborations.

Funding: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs

Duration: 1-2 years for pre-clinical programs, 2-3 years for clinical programs

https://www.michaeljfox.org/grant/parkinsons-disease-therapeutics-pipeline-program?em_cid=mc-a1bHq00000AbgaK

29.7 | Cystic Fibrosis Foundation: Path to a Cure, collaborative Research Grant

To facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches.

Funding: max of $1,000,000 per year for up to 3 years. The application must consist of at least two (2) projects, each led by an independent

investigator.

https://www.cff.org/researchers/path-cure-collaborative-research-grant

30.7 | Wellcome Trust: Discovery Awards

Funding: the average size of a Discovery Award is £3.5 million, although the trust have supported awards from £700,000 to £8 million.

Please note: the host organisation of the lead applicant needs to be based in UK, Republic of Ireland, Low- or middle-income countries

https://wellcome.org/grant-funding/schemes/discovery-awards

31.7 | National Eczema Association

Engagement Research Grant – up to $5,000
Small research grants for emerging investigators intended to explore a new research concept, pilot a new experiment or undertake a novel or secondary data analysis.

Catalyst Research Grant – up to $50,000
Designed to support talented early-career scientists on the path toward becoming the next generation of eczema thought leaders by supporting hypothesis-driven research projects.

Childhood Eczema Challenge Grant – up to $50,000

This collaborative grant with the Pediatric Dermatology Research Alliance (PeDRA) supports targeted clinical research investigations focused on pediatric eczema. This award is intended to stimulate early and mid-career scientists as they seek to build and sustain careers as research investigators and future thought leaders within this critical field of study.

Spotlight Research Grant – up to $60,000

This award is intended to promote research in topic areas of special interest that relate to NEA’s advancement of our overall research priorities for eczema

Eczema Champion Research Grant – up to $100,000
Encourages proven researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema.

https://nationaleczema.org/research/research-we-fund/for-researchers/

7.8 | Foundation for Food & Agriculture Research (FFAR): Harvest for Health Breakthrough Crop Challenge (Part 2: Predictive Model Development and Validation)

The purpose is to develop a predictive model to determine a crop’s potential as a source of ingredients with the following functional properties:

• Thickeners, emulsifiers, and stabilizers

• Bulking agents

• Taste and flavor enhancers

• High nutrient density (specific nutrients to be proposed by applicants)

(Participating in the seed funding part is not a requirement for applying to the predictive model development and validation part).

Funding: $1.0 million (one award)

https://foundationfar.org/grants-funding/opportunities/harvest-for-health-breakthrough-crop-challenge-2/

https://foundationfar.org/wp-content/uploads/2023/07/Harvest-for-Health-Breakthrough-Crop-Challenge-Submission-Criteria.pdf

Informational webinar will be hold on October 3, at noon EDT, register to attend the webinar (mandatory).

15.8 | Friedreich's Ataxia Research Alliance (FARA) - LOIs

General Research Grant

Supports research across the spectrum from basic research through drug development and clinical research programs in Friedreich's Ataxia (FA).

Funding: $125K for 1-2 years

FARA is willing to consider ad-hoc proposals of cycle that are high-value projects. For more information, please contact FARA at grants@curefa.org

Postdoctoral Research Award

To expand and retain young investigators in the FA biomedical research space. Eligible applicants are postdoctoral trainees with fewer than 7 years working as a postdoctoral trainee, accounting for career disruptions.

Funding: $100K for 1-2 years

https://www.curefa.org/grant/grant-apply

16.8 | John Templeton Foundation: Core Funding Areas - Online Funding Inquiry Form

Invest in bold ideas from contrarian thinkers — ideas that cross disciplinary boundaries and challenge conventional assumptions. Welcomes grant applications to support field-leading research and high-impact public engagement programs in these areas.

· Character Virtue Development

· Individual Freedom & Free Markets

· Life Sciences

· Mathematical & Physical Sciences

· Public Engagement

· Religion, Science, and Society

Funding: Not specified. Duration: up to 5 years.

www.templeton.org/what-we-fund/core-funding-areas

25.8 | Pfizer: Independent Research Grants

General Research: general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset.

Funding: not specified.

https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research

31.8 | AO Foundation: Biomedical Innovation Funding

Eligible projects must focus on either:

Clinical tools and technologies for any element of the entire patient journey in musculoskeletal disorders, from diagnosis to post-operative care; or

Educational tools, platforms or channels for lifelong training of surgeons.

https://www.aofoundation.org/what-we-do/innovation-translation/innovation-funding

31.8 | Fritz Thyssen Foundation: Conferences in Medicine and Natural Sciences, Humanities and Social Sciences

(another deadline in: November 30)

Clear connection to the German research system (topic, scientist, institute). Interdisciplinary projects welcomed.

Areas of support:

- History, Language & Culture

- State, Economy and Society

- Medicine and the Natural Sciences

15 to 20 speakers, not earlier than 6 months after application submission, not for a staged conference.

https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/

31.8 | International Team for Implantology (ITI): Research Grant

Projects in the field of implant dentistry and related areas.

Small Grant (SG)

For young researchers who wish to expand their scope and level of responsibility or want to establish a track record in implant dentistry.

Funding: $50K

Large Grant (LG)

This grant type will be awarded to experienced researchers/research groups only.

Funding: $200K

https://www.iti.org/research/research-grants

1.9 | Fritz Thyssen Foundation: Medicine and Natural Sciences, Humanities and Social Sciences

Projects with clear connection to the German research system (topic, scientist, institute). Interdisciplinary projects welcomed.

Areas of support:

- History, Language & Culture

- State, Economy and Society

- Medicine and the Natural Sciences

Funding: not specified. Up to 3 years.

Travel Subsidies applications related to a project can be submitted seperatly at any time.

Note: please contact Research Authority if planning to submit - overhead not covered

https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/

1.9 | Mizutani Foundation for Glycoscience

Provides research grants to proposals for basic and applied studies on glycoconjugate.

Funding: up to 7,000,000 yen (~$48K) for 1 year.

https://mizutanifdn.or.jp/grant/apply.html

2.9 | European Pain Federation EFIC: The EFIC-Grünenthal-Grant (E-G-G)

Clinical and human experimental pain research including innovative educational initiatives aimed at improving diagnosis and treatment of pain. Research proposals on animals, computer simulations, cell lines, etc. will not be considered. For early-career scientists, holding a PhD degree (for a maximum of 7 years on 2 September 2024).

Funding: up to 50K EUR for 2 years

https://europeanpainfederation.eu/efic-grunenthal-grant/

https://www.grunenthal.com/en/world-free-of-pain/initiatives/e-g-g

3.9 | Parkinson's UK: Drug Accelerator Awards - preproposals

Projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson’s.Co-applicants and collaborators may be based at institutions outside the UK or biotech companies.

Funding: up to 100K EUR for up to 12 months. For projects involving in vivo work, a duration of 12 to 18 months and an award amount of up to £150K will be considered.

https://www.parkinsons.org.uk/research/drug-accelerator-awards

https://www.ra.trdf.co.il/files/Drug accelerator award.pdf

A virtual workshop will be held on July 12, for registration: https://parkinsons-org-uk.zoom.us/meeting/register/tZErceGoqTksH9FX37TTu4mZp91ax5UZ2tbk#/registration

3.9 | Volkswagen Shiftung: Pioneering Research – Exploring the Unknown Unknown

For visionary projects from the field of basic research. Addresses outstanding researchers from all disciplines and is open to various funding formats.

Funding: up to 500K EUR for up to 3 years

https://www.volkswagenstiftung.de/en/funding/funding-offer/pioneering-research-exploring-unknown-unknown

6.9 | March of Dimes: Discovery Grants

Researchers seeking to make consequential translational discoveries that will drastically alter clinical care for pregnant women and babies, whether through evidence-based prevention, diagnosis, or intervention.

Funding: $200K for 2 years

https://www.marchofdimes.org/our-work/research/grants-awards/discovery-research-grants

12.9 | LEO Foundation: Dermatology research projects

Call opens on Aug. 1

- Improve the understanding of skin biology as well as the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.

- Address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.

Funding: DKK 2-4 million ($300-600K), %5 Overhead is covered

https://leo-foundation.org/en/grants-and-awards/research-grants/ \ Call Guidelines

13.9 | ChadTough Defeat DIPG Foundation: Fellowship Grant

Intended to incentivize novel approaches and spark innovation to find a cure for the deadliest pediatric brain cancer, DIPG.

Post-doctoral fellows under the guidance of a mentor to help develop the next generation of leaders in DIPG research.

Funding: up to $135K/year for 3 years, No overhead

https://www.chadtough.org/research/grant-application/

15.9 | GenScript Life Science: Research Grant Program

Funding: $100K for up to 12 months

https://www.genscript.com/grantprogram.html

https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf

15.9 | Ulverscroft Foundation: Grants for visually impaired people

Supports projects which will have a positive effect on the quality of life of visually impaired people (VI). Funding: not specified.

www.ulverscroft-foundation.org.uk/grants/

16.9 | National Scleroderma Foundation: Established Investigator Grant

To propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease,

that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.

Funding: up to $200K for up to 2 years (Non-profit)

https://scleroderma.org/grant-opportunities/

23.9 | VELUX STIFTUNG - Forestry

- Innovative, sustainable and integrative forest management to develop and provide solutions for adapting to or mitigating climate change, promoting biodiversity, providing resilient ecosystem services while supplying sustainable forest products.

- Incentives for action and behavioural chang by transforming theoretical and abstract values of forest products and services.

Funding: CHF 50-70K ($57-114K) per year for 1-4 years (possbile to exceed with pre-approval)

https://veluxstiftung.ch/funding-areas/forestry/

30.9 | The Frick Foundation: Starting grants in ALS basic research

For talented early-career scientists who have already produced excellent supervised work, ready to work independently and shows potential to be a research leader.

Funding: 100K Swiss francs ($111K) for 2 years

https://frick-fondation.ch/

30.9 | Benign Essential Blepharospasm Research Foundation (BEBRF): Research grant

Supports research directly related to the cause of, treatments for, and complications derived from treatments for benign essential blepharospasm or Meige Syndrome, both forms of cranial dystonia.

Funding: up to $50K for 1 year

https://blepharospasm.org/apply-for-a-grant/

30.9 | Thermo Fisher Scientific: Oncomine Clinical Research Grant - Molecular Profiling in Oncology

Proposals addressing unmet diagnostic needs using next-generation sequencing for both solid and hematological cancers.

Funding: up to $200K

www.oncomine.com/grants

30.9 | VELUX STIFTUNG

Daylight Research

Highly interdisciplinary, on the effects and utilization of daylight in three fields:

- Daylight and humans

- Daylight and nature

- Daylight technology

Healthy Aging

Bio-psycho-social approach and support research that aims to sustain or increase the functional ability and intrinsic capacity of older people.

Funding: CHF 50-70K ($57-114K) per year for 1-4 years (possible to exceed with pre-approval)

https://veluxstiftung.ch/funding-areas/daylight-research/

https://veluxstiftung.ch/funding-areas/healthy-ageing/

30.9 | Alzheimer’s Drug Discovery Foundation (ADDF) – Letter of intent

* Drug Development: up to $5M.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/drug-development-rfp

* Neuroimaging and CSF Biomarker: $600K for 1 year

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers

* Prevention: up to $5M for clinical trials based on stage and scope of research.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/prevention-pipeline

Please note overhead is not covered.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities

1.10 | LEO Foundation: Education and awareness grants

Call opens on Aug. 20, Projects must be carried out in Denmark

Welcomed application:

- Spur the interest and strengthen the capabilities of children and young people within the STEM (science, technology, engineering, and mathematics) fields.

- Disseminate research-based knowledge to the public. increase public awareness about science and its role in developing our society.

- Promote public knowledge and understanding about skin, skin health, and skin diseases.

Funding: below or above DDK 1 ($145K) - different requirements for proposal and evaluation.

https://leo-foundation.org/en/grants-and-awards/research-grants/ \ Call guidelines

3.10 | CurePSP: Grant program

Pathway Grants

Support projects studying the fundamental neurobiology of PSP and CBD, to improve understanding of diseases and provide the foundation for future treatments. Studies focusing on mechanisms common to multiple neurogenerative are strongly encouraged.

Pipeline Grants

Support translational projects focusing on new therapeutics and biomarkers for PSP and CBD. Aimed to accelerate the development of therapeutics that have the potential to prevent, treat, or cure PSP and CBD by accelerating the translation of basic science discoveries into novel therapeutics.

Funding: Up to $100K for 1-2 years (Non-profit)

https://www.psp.org/for-researchers

5.10 | US Department of Health & Human Services/Office of Biomedical Advance

Research and Development Authority (BARDA): Division of Research, Innovation & Ventures (DRIVe) -(Abstracts) (Abstracts may be submitted at any time until the closing date)

AOI #25 - FASTx Nucleic acid-based platform development for Flexible and Strategic Therapeutics

submissions of projects that aim to advance the development of rapid response, nucleic acid-based platforms for the treatment of viral infections from multiple viral families. These platforms may include, but are not limited to, nucleic acid-expressed mAbs, double-stranded RNA-mediated interference (RNAi), clustered regular interspaced short palindromic repeat-associated proteins (CRISPR-Cas), and locked nucleic acids (LNAs).

Funding: up to $750K.

https://drive.hhs.gov/partner.html

https://sam.gov/api/prod/opps/v3/opportunities/resources/files/d1b4dc337cd942e5bb3bad852b71c14c/download?&token=

14.10 | Promobilia Foundation: Research Projects

Foster the development and dissemination of technical aids, with a particular emphasis on enhancing mobility, alongside supporting scientific research to create new aids and restore mobility and communication capabilities for individuals with disabilities.

Only projects affiliated with Swedish organizations, or their equivalents are eligible for application. In certain instances, projects conducted abroad may also be considered for application.

Funding: up to 500K SEK ($48K) per year for a max period of 3 years (Non-profit)

https://www.promobilia.se/en/apply-for-project-grants/

15.10 | Angelman Syndrome Foundation

Priority will be given to the following topics:

- Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.

- Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.

- Projects studying delivery of therapies and potential for improvement.

- Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.

Proposals that do not address these topics are still welcome and will be given full consideration.

Funding: $100K per year for 1 or two years

https://www.angelman.org/as-research/call-for-proposals

21.10 | CURE Parkinson's: Quarterly Research Grant Funding Programme

Funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

Funding: up to £250K (GBP) and prioritize projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years.

https://cureparkinsons.org.uk/for-researchers/apply-for-funding/quarterly-research-grant-funding/

31.10 | The Morton Cure Paralysis Fund (MCPF): Research Grants

Funding: $5K to $75K for 1 year (second year considered, no overhead)

https://www.ra.trdf.co.il/files/MCPF-Research-Guidelines-2023.doc

https://mcpf.org/new-investigator-grant-application/

15.11 | GenScript Life Science: Research Grant Program

Funding: $100K for up to 12 months

https://www.genscript.com/grantprogram.html

https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf

30.11 | Fritz Thyssen Foundation: Conferences in Medicine and Natural Sciences, Humanities and Social Sciences

Clear connection to the German research system (topic, scientist, institute). Interdisciplinary projects welcomed.

Areas of support:

- History, Language & Culture

- State, Economy and Society

- Medicine and the Natural Sciences

15 to 20 speakers, not earlier than 6 months after application submission, not for a staged conference.

https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/

1.12 | Environmental Research & Education Foundation- Pre-proposals

Topic areas:

Waste minimization, Recycling, Waste conversion to energy, biofuels, chemicals or other useful products. This includes, but is not limited to, the following technologies:

Funding: average of $160K for about 2 years

https://erefdn.org/research-grants-projects/how-to-apply-for-grant/

5.12 | Cystic Fibrosis Foundation

Pilot and Feasibility Awards

Intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.

Funding: $50K per year for up to 2 years

https://www.ra.trdf.co.il/files/Pilot-and-Feasibility-Awards.pdf

https://www.cff.org/researchers/pilot-and-feasibility-awards

Path to a Cure Pilot and Feasibility Awards

Supports research that will accelerate the discovery and development of therapies to restore cystic fibrosis transmembrane conductance regulator (CFTR) function in all patients with cystic fibrosis.

Funding: $50,000 per year for up to 2 years

https://www.ra.trdf.co.il/files/PTAC-Pilot-and-Feasibility-Award.pdf

https://www.cff.org/researchers/path-cure-academic-programs

Research Grants

To support (non-Path to a Cure related) basic science research that will provide new insights that contribute to the understanding of the basic etiology and pathogenesis of cystic fibrosis.

Funding: $150K per year for up to 3 years

https://www.ra.trdf.co.il/files/Research-Grants.pdf

https://www.cff.org/researchers/research-grants

Path to a Cure Research Grants

To support basic science research that may enable the development of new therapies that directly impact CFTR function.

Funding: $150K per year for up to 3 years

https://www.ra.trdf.co.il/files/PTAC-Research-Grants.pdf

https://www.cff.org/researchers/research-grants

30.9.27 | US Army Medical Research and Development Command: Broad Agency Announcement (BAA) for Extramural Medical Research

(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)

Research Areas of Interest (please see BAA for more details)

I. Military Infectious Diseases Research Program

Research and development of solutions for the prevention, treatment, and diagnosis of infectious diseases

II. Combat Casualty Care Research Program

A. technologies to stop blood loss, resuscitate the casualty, and limit the immediate, short-, and long-term deleterious consequences of severe hemorrhage:

B technologies to diagnose and to limit the immediate, short-, and long-term impairments that follow TBI

C. technologies to diagnose and reduce acute secondary organ damage

D. The delivery of care during transport

E. Clinical practice of novel/optimized treatments for severe burn injuries

F. Pain Management

G. Regenerative Medicine

H. Autonomous Care and Evacuation / Medical Assist Support Technologies (MAST)

I. Medical Countermeasures (MCMs) for Acute Radiation Exposure

J. Combined Injury

III. Military Operational Medicine Research Program

A. Injury Prevention and Treatment

B. Psychological Health and Resilience

C. Physiological Health and Performance

D. Environmental Health and Protection

IV. Medical Biological Defense Research Program

A. Viral, Toxin, and Bacterial Studies

B. Drug Development

C. Identification, Diagnosis, and other Medical Interventions

D. Biosurveillance (BSV)

V. Medical Chemical Defense Research Program

Funding: not specified. Duration: 4 years.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549112

https://www.grants.gov/web/grants/search-grants.html?keywords=Extramural%20Medical%20Research

18.10.27 | US Department of Health & Human Services/Office of Biomedical Advanced

Research and Development Authority (BARDA): Division of Research, Innovation & Ventures (DRIVe)- (Abstracts) (Abstracts may be submitted at any time until the closing date)

AOI #20 DRIVe Forward

Aims to develop products, capabilities, and technologies to detect threats, improve patient care, including ancillary supplies and resources, as well as novel approaches to develop, clinically validate, and deploy/distribute MCMs rapidly and agnostically.

Especially interested in proposals that aim to address one or more of the following topics:

1. Microbiome-based therapies

2. Resilience to infection

3. Next-generation vaccines

4. Next-generation therapeutic antibodies

5. Artificial blood products

6. Extremely mobile viral diagnostic platforms for use in extremely remote settings

7. Non-pharmacological approaches for enhanced immunity

Funding: up to $750K.

https://drive.hhs.gov/partner.html

https://drive.hhs.gov/files/ezbaa_files/DRIVe_EZ-BAA_Special_Instructions_01.pdf

20.11.27 | DOD/ DEVCOM Army Rsearch Laboratory (ARL): Broad Agency Announcement (BAA) Foundational Research (W911NF-23-S-0001)

(Accepting applications on a rolling basis until the deadline)

Research Areas of Interest (please see BAA for more details)

DEVCOM ARL executes intramural and extramural research organized by eleven competencies

that provide the Army with foundational expertise and specialized capabilities grounded in

scientific excellence and driven by unique Army challenges.

The eleven DEVCOM ARL competencies are:

 Biological and Biotechnology Sciences

 Electromagnetic Spectrum Sciences

 Energy Sciences

 Humans in Complex Systems

 Mechanical Sciences

 Military Information Sciences

 Network, Cyber, and Computational Sciences

 Photonics, Electronics, and Quantum Sciences

 Sciences of Extreme Materials

 Terminal Effects

 Weapons Sciences

https://www.grants.gov/search-results-detail/344592

For the full list of opportunities under this BAA:

https://cftste.experience.crmforce.mil/arlext/s/arl-opportunities

31.7.28 | DOD/ United States Special Operations Command (USSOCOM): Broad Agency Announcement (BAA) Extramural Biomedical and Human Performance Research and Development (HT9425-23-S-SOC1)

(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)

Research Areas of Interest (please see BAA for more details)

1. Damage Control Resuscitation

2. Prolonged Field Care (PFC)

3. Portable Lab Assays and Diagnostics

4. Force Health Protection and Environmental Medicine

5. Brain Health

6. Immune Response

7. Chronic Pain

8. Automation of Systematic Reviews and Metanalysis:

9. Medical Simulation and Training Technologies

10. Human Performance Optimization

11. Canine Medicine and Performance:

Most projects are anticipated to have a total cost at or below $1,500,000 (including indirect costs). Projects that have a total cost higher than $1,500,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $5,000,000.00 (including Indirect costs).

Duration: up to 5 years.

https://globalbiodefense.com/2023/07/29/socom-seeks-development-of-lightweight-ruggedized-biomedical-tools/

https://www.grants.gov/web/grants/view-opportunity.html?oppId=349586

Open until suspended | U.S. Air Force (AFOSR): Research Interests of the Air Force – Engineering, Complex systems, Information and networks, Chemistry, Physical, Biological sciences (FA9550-23-S-0001)

(Open on an ongoing basis until superseded)

AFOSR is looking for new basic research ideas and is open to considering any unique and revolutionary concepts (pre-coordination is strongly encouraged). Funding ranges are $100-300K per year for 3 to 5 years.

ENGINEERING AND COMPLEX SYSTEMS

· Dynamic Materials and Interactions

· GHz-THz Electronics

· Energy, Combustion and Non-Equilibrium Thermodynamics

· Unsteady Aerodynamics and Turbulent Flows

· High-Speed Aerodynamics

· Aerospace Composite Materials

· Multiscale Structural Mechanics and prognosis

· Propulsion and Power

· Agile Science for Test and Evaluation

INFORMATION AND NETWORKS

· Computational Cognition and Machine Intelligence

· Computational Mathematics

· Dynamical Systems and Control Theory

· Dynamic Data and Information Processing

· Information Assurance and Cybersecurity

· Mathematical Optimization

· Science of Information, Computation, Learning, and Fusion

· Trust and Influence

· Complex Networks

· Cognitive and Computational Neuroscience

PHYSICAL SCIENCES

· Aerospace Materials for Extreme Environments

· Atomic and Molecular Physics

· Electromagnetics

· Optoelectronics and Photonics

· High Energy Radiation Matter Systems

· Quantum Information Sciences

· Physics of Sensing

· Space Science

· Ultrashort Pulse Laser-Matter Interactions

· Condensed Matter Physics

· Astrodynamics

CHEMISTRY AND BIOLOGICAL

· Biophysics

· Human Performance and Biosystems

· Mechanics of Multifunctional Materials and Microsystems

· Molecular Dynamics and Theoretical Chemistry

· Natural Materials and Systems

· Organic Materials Chemistry

https://www.grants.gov/web/grants/search-grants.html

Foreign - all year round:

DFG – German Science Foundation: Research Training Group and International Research Training Groups

Research Training Groups (comprised of one or more universities) are established to promote young researchers; they are run by 5-10 professors with expertise in any field. There are two program profiles: 1) research: focuses on one main topic; and 2) qualification: enables doctoral researchers to produce independent research findings with international visibility, and simultaneously qualify for domestic and international academic and non-academic job market.

International research training groups are structured doctoral programs run by German universities in conjunction with universities abroad, promoting systematic research cooperation from the partner group.

There is a two-stage proposal process: draft proposal that leads to invitation for full proposal. Funding is for nine years in two 4.5 year segments.

http://www.dfg.de/en/research_funding/programmes/coordinated_programmes/research_training_groups/index.html

http://www.dfg.de/formulare/54_05/

DFG – German Science Foundation: Grants to Support the Initiation of International Collaboration

Funds collaborative activities, such as three-month research stays at partner institutions, guest visits, or joint workshops, between international partners.

http://www.dfg.de/en/research_funding/programmes/international_cooperation/initiation_international_collaboration/index.html

http://www.dfg.de/formulare/1_813/1_813_en.pdf

AstraZeneca: Open Innovations

Preclinical research opportunities

Cell therapy: Explore and identify new compounds from a subset of AstraZeneca small molecules with the potential to act as cell modulators in regenerative medicine,

Cell modulation with therapeutic antibodies, novel approaches, and technologies for the generation of hypoimmunogenic ‘universal cells.

Preclinical molecules: Identifying disease targets for active molecules is integral to modern drug discovery.

Drug Delivery: particularly interested in the following drug delivery approaches:

- Technologies that facilitate oral delivery of macromolecules

- Approaches for elongating dosing intervals, e.g. long-acting delivery systems for peptides and oligonucleotides that can enable monthly or biannual dosing

- Technologies or compounds that offer patient-centric approaches to drug delivery and/or offer attractive alternatives to injectables, e.g. macromolecule transdermal delivery

- Approaches for targeted delivery of large nucleic acids ready for clinical translation

Preclinical data (no funding, only collaboration): for data, analytical or computer science research groups that profile data sets with algorithms to interrogate patterns in data and link to biological outcomes. Allow to get access to unpublished data. Publications encouraged.

Clinical research opportunities (no funding, only collaboration)

Target identification): gain access to high-quality diversity screening sets for use in hit identification.

Clinical molecules: to test our molecules in clinical indications that they have not previously been tested in.

Human biological samples): gain access to a broad range of analytical methods, including genome sequencing, RNAseq, proteomics, metabolomics, and a novel multi-omics integration pipeline. open to basic and applied researchers with appropriate patient samples, the ability to share them, and utilize the data generated.

Translational data:

Data, analytical, or computer science research groups with algorithms to interrogate data patterns and link them to biological outcomes. Publications encouraged.

CoSolve

CoSolve Sprints - Novel Antibodies Targeting COVID: innovative solutions to challenges currently facing our R&D teams.

A. Catalyst Network - open a hub.

Unites entrepreneurs, start-ups, academics, governments, healthcare institutions and other industries from all around the world under one common goal.

https://az-portal-ex.idea-point.com/Default.aspx?groupid=null

Sanofi Regeneron: Global Innovation Grant – Pathways in Type 2 Inflammation

Research in type 2 inflammation and its associated diseases, including atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps or other type 2 immune-mediated diseases that are relevant in clinical practice. Funding: up to $1 million

www.globalt2grant.com

National Spasmodic Dysphonia Association (NSDA)

Supports research for spasmodic dysphonia and related voice conditions. Funding: 75,000 for 1 year.

https://dysphonia.org/research/nsda-research-grants/

MSSNG - genomic database on AUTISM

Genomic database on autism. A resources to enable the identification of many subtypes of autism, which may lead to better diagnostics, as well as personalized and more accurate treatments

https://research.mss.ng/visitors/about

MdDS Balance Disorder Foundation Research Grant

supports biomedical research that generates evidence-based data leading to knowledge regarding the cause, treatment, or prevention of Mal de Débarquement Syndrome (MdDS).

Funding: The size of the grant is determined on a case-by-case basis. The grant may cover indirect costs or institutional overhead (limited to 10%) for applications in excess of $30,000 direct costs.

https://mddsfoundation.org/apply-for-a-grant/

Rett Syndrome Research Trust (RSRT)

RSRT does not have funding calls. We do however accept unsolicited proposals. Please submit a short (between one and two pages) letter of intent to monica@rsrt.org outlining your project, timeline, and rough budget. There are no deadlines for submission.

Myrovlytis Trust: Birt-Hogg Dubé Syndrome, related kidney disorders and osteosarcoma

Promotes research into molecular genetics, clinical investigations and therapeutic technologies so as to better understand, prevent, diagnose, relieve and ultimately cure symptoms caused by Birt-Hogg-Dubé (BHD) Syndrome, BHD related kidney disorders and osteosarcoma.

Welcome initial pre-proposals before submission of the full grant application form. Pre-proposals should be emailed to: grants@myrovlytistrust.org.

https://myrovlytistrust.org/home/apply-for-funding

Cystic Fibrosis Foundation: Path to a Cure — Pioneer Award - Rolling competitive LOI

(Closes on December 13, 2024)

For exceptional investigators developing paradigm shifting technologies that could ultimately lead to a cure for CF. Proposals should be

ambitious and utilize cutting edge techniques and strategies.

https://www.cff.org/researchers/path-cure-pioneer-award

https://www.ra.trdf.co.il/files/Path to a Cure.pdf

Lundbeck Foundation: Frontier Grants

Facilitate transitions from basic research to attractive prospects for biotech investors, to advance mature research projects to become financeable and commercially tangible venture opportunities.

The research must be affiliated with a Danish non-commercial research institution – international collaboration is allowed.

Funding: up to DKK 5M ($730K) over 18 months

https://lundbeckfonden.com/uddelinger-priser/ansoegere/apply-grants/frontier-grants

Cancer Research:

The Johns Hopkins University School of Medicine: Neurofibromatosis Therapeutic Acceleration Program (NTAP)

Accepting applications on a rolling basis

To accelerate development of effective treatments for NF1 associated peripheral nerve sheath tumors.

No fixed budget, not set time frame (usually 2-3 years)

https://www.ra.trdf.co.il/files/PRDESC6990.pdf

Rising Tide Foundation for Clinical Cancer Research: Cancer Research Program – LOI

Supports patient-centered clinical research that has the potential to positively impact the lives of cancer patients at the earliest opportunity. We do not provide funding for basic research. Two umbrella themes: Improved Patient Outcomes and Science of Early Detection and Intervention. Funding: unspecified, based on the objectives of each grant and availability. Duration up to 5 years. No overhead. Nonprofit.

https://www.risingtide-foundation.org/freedom-in-practice/

Lyla Nsouli Foundation: Diffuse Intrinsic Pontine Glioma (DIPG)

Supports research to improve the prognosis and find a cure for brain cancers, with a focus on Diffuse Intrinsic Pontine Glioma (DIPG). Application on a rolling basis. Funding: up to $300,000.

www.lylansoulifoundation.org/research-and-grants/what-we-fund.php

Pediatric Brain Tumor Foundation: Brain Tumor / Low-grade Glioma ad Astrocytoma (PLGG/PLGA) Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of PLGA tumors will be considered. Investigators in the early years of their careers are encouraged to apply. Funding can be awarded over one to three years.

www.curethekids.org/research/apply-for-funding

James S. McDonnell Foundation: Collaborative Activity Awards supports research in 3 areas: Bridging Brain, Mind, and Behavior; Complex Systems; and Brain Cancer Research. These awards support study panels, research networks or other ways of pushing work on mind/brain forward outside the usual mechanism of investigator-initiated research proposals. The collaborative award process is not used to support meetings, conferences, etc.

www.jsmf.org/apply/collaborative/index.htm

Accelerate Brain Cancer Cure: Basic and Clinical Research Grants - Initial research summary

Aim: Accelerating the development of new brain tumor treatments, at each stage of the drug development pipeline, to ensure promising leads are advanced as quickly as possible. Request to initially submit a 1000 word research summary.

http://abc2.org/smarter-research/how-we-fund

Neurological Disorders and NeuroScience:

Cure LGS 365 Research Grants: Lennox-Gastaut Syndrome

Lennox-Gastaut syndrome (LGS) is a developmental brain disorder that frequently evolves from early-life-onset epilepsy. The LGS Foundation accepts unsolicited proposals year-round to seed new LGS research projects. Projects may be funded at the $25,000, $50,000, or $75,000 level.

https://www.lgsfoundation.org/365-research-grants/

CMT Research Foundation - Funding Priorities - LOI

Supports translational research to support promising therapeutic approaches for the cure of CMT diseases. Research funding will be targeted (but not limited) to the key focuses here after: Pharmacodynamic Barriers; CMT Molecular Drug Targets; Pathophysiologically Relevant Animal Models and Stem Cell Derived Cellular models of CMT. Funding: $100,000-$150,000 for 1 year.

This funding is available on a rolling basis. To ensure that the proposed research is aligned with the funding focus, applicants are required to first submit a one-page letter of intent.

https://cmtrf.org/apply/

CHDI Foundation - accelerating theraputic development for Huntington's disease (LOI)

CHDI Foundation is exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of individuals with HD

Funding and project duration: unspecified

https://chdifoundation.org/academic-proposals/

Alzheimer’s Association: Global Real-World Data Platforms (ALZ-RWD)

Accept submissions on a rolling basis

Discovery, evaluation and evolution of novel avenues for the diagnosis, prevention, treatment and care of Alzheimer’s and other dementia.

Funding: from $100K up to $1M for 12-24 months (no overhead)

https://www.ra.trdf.co.il/files/Global Real-World Data Platforms.pdf

Alzheimer’s Drug Discovery Foundation (ADDF): Diagnostics Accelerator (DA)

Development of cutting-edge biomarkers and novel diagnostic technologies that will aid in Alzheimer’s diagnosis and clinical trial design. Research funded to date focuses on various methods and targets including blood tests in various stages of development, as well as eye scans and digital tools. These awards focus on true collaboration among renown clinicians, directly involved with patients and understand the disease, scientists developing the tests, and diagnostics companies that understand the regulatory pathways – driving research and product development.

The program has two sub-domains with funding of up to $500K each: Peripheral Biomarkers / Digital Biomarkers

www.alzdiscovery.org/research-and-grants/diagnostics-accelerator

* www.alzdiscovery.org/research-and-grants/funding-opportunities/diagnostics-accelerator-program

* www.alzdiscovery.org/research-and-grants/funding-opportunities/digital-biomarkers

Cure Alzheimer’s Fund – rolling acceptance of LOIs

Aim: to fund research with the potential to accelerate a cure or disease-modifying treatment for Alzheimer’s disease.

Current areas of investigation: Fundamental / Translational / Drug discovery / Preclinical and clinical drug development.

Funding: not specified.

Non-profit - Please contact Research Authority if planning to submit.

https://curealz.org/the-research/grant-process/

STXBP1 Foundation: (LOI)

Aim: broaden understanding of STXBP1 biology and develop safe and transformative therapies for STXBP1 related disorders.

These areas include but are not limited to the following: Biomarkers and clinical endpoints development / Neurodegeneration / Pathomechanisms of STXBP1 mutations and genotype-phenotype relationships / Non-CNS functions of STXBP1 / New Therapeutics and Drug repurposing.

Seed Grant: up to $25K for 1 year.

Trainee Grant: up to $60K for 1.

Innovation Grant: up to $100K for 1 year.

(No overhead).

https://www.stxbp1disorders.org/applyforagrant

Parkinson's Foundation: Conference Awards

Support the gathering of experts in the field working to address unsolved clinical or basic science problems relevant to Parkinson's disease.

Funding: $10K - $15K per award

Please contact Grants@Parkinson.org if you are interested to apply.

https://www.parkinson.org/advancing-research/for-researchers/awards-independent-investigators#ConferenceAwards

Michael J. Fox Parkinson Foundation: Parkinson's Disease Therapeutics Pipeline Program

Aim: to accelerate pre-clinical and clinical therapeutic development of interventions that may reduce, slow or prevent disabling motor or non-motor symptoms of Parkinson’s disease not well managed by current treatments.

Funding: up to $2M over 18-24 months. Duration: 1 to 2 years for pre-clinical programs and 2 to 3 years for clinical programs

https://www.michaeljfox.org/grant/parkinsons-disease-therapeutics-pipeline-program

Other

The LAM Foundation: Out-of-Cycle Grant Opportunities

Bridge funding on a case-by-case basis. Targeted towards Principal Investigators (PIs) that have an external grant under review and will exhaust current funding prior to the Notice of Award, equiring funds to sustain their program/laboratory, or have a previously submitted grant being prepared for resubmission but need funding to execute experiments or retain personnel during a funding gap.

Funding: up to $75K in increments of $25K for a maximum period of 1 year

For more information about bridge funding and prior to applying, please contact The LAM Foundation at research@thelamfoundation.org.

https://www.thelamfoundation.org/investigators/funding-opportunities/

FRAXA Research Foundation: FRAXA Fellowships

Priority is given to research with a translational or preclinical focus on Fragile X, which has potential to lead to improved treatment.

Funding: $50K per year for up to 2 years (Non-profit)

https://www.fraxa.org/fragile-x-research/grant-application/

The American Tinnitus Association (ATA): Innovative Grants Research Program

Application on a rolling basis, LOI to: grants@ata.org is required 1-month before applying.

1. Established Investigators, max $60K/year for 2 years

2. Early Investigators, max $25K/year

Encourages a multidisciplinary approach to solve the complex and variable experience within tinnitus research, clinical care, and patient outcomes.

https://www.ata.org/wp-content/uploads/2023/02/ATA_Grants_Instructions.pdf

Humboldt Foundation

Friedrich Wilhelm Bessel Research Awards

Awarded to outstanding accomplishments in research, if they are expected to continue producing cutting-edge academic achievements and have a lasting impact beyond their area of specialization. Academics, regardless of their discipline or nationality, may be nominated, provided that they have received their doctoral degree within the past 18 years. Award winners are invited to conduct a research project of their own choosing in Germany in close collaboration with a specialist colleague. Project duration 6-12 months. Award amount is €45,000. Self-nomination is not possible. Nomination processing normally takes up to six months, selection committee meetings are held twice a year – currently at the beginning of spring and in early autumn.

http://www.humboldt-foundation.de/web/bessel-award.html

Humboldt Research Fellowship for Experienced Researchers

For highly-qualified scientists and scholars from abroad, who completed their doctorates less than 12 years ago to spend extended periods of research (6-18 months; may be divided up into a maximum of three blocks) in Germany. Candidates are expected to have their own, clearly defined research profile. Funding: fellowship of €3,150 per month. The selection committee meets every year in March, July and November.

http://www.humboldt-foundation.de/web/humboldt-fellowship-experienced.html

Humboldt Research Award

The award is granted in recognition of a researcher's entire achievements to date to academics whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future. Award winners are invited to spend a period of up to one year cooperating on a long-term research project with specialist colleagues at a research institution in Germany. Nominations may be submitted by established academics in Germany or by award winners of the Humboldt Foundation working abroad, provided that the nomination is made jointly with a colleague working in Germany. Direct applications are not accepted. The award is valued at €60,000. Selection Committee meetings are held twice a year – currently at the beginning of spring and in early autumn.

http://www.humboldt-foundation.de/web/humboldt-award.html

Reimar Lüst Award for International Scholarly and Cultural Exchange

Highly respected humanities scholars and social scientists. For multipliers making exceptional contributions in and through science to the long-term advancement of bilateral relations between Germany and their home countries. Part of the ‘Humboldt Research Award’.

Reimar Lüst Award for International Scholarly and Cultural Exchange - Alexander von Humboldt-Foundation

Foundation for Food & Agriculture Research (FFAR): Research Concept

Funds food and agriculture science that addresses large-scale challenges to develop actionable knowledge and solutions.

Challenge Areas:

*Soil health; *Sustainable water management; *Next generation corps; *Advanced animal system; *Urban food systems; *Health agriculture Nexus.

Funding: Not specified (Please note: Matching).

https://foundationfar.org/grants-funding/open-opportunities/

The Campbell Foundation Funding AIDS Research: Research Grants (LOI)

LOIs should include a brief description of the research aims, an approximate one-year budget, a list of collaborating research teams, how it is novel research, and an explanation of how the project will apply to the HIV community at large within five to seven years from date of completion. Funding from $60,000 to $100,000 for 1 year. (Please contact research Authority if planning to submit- nonprofit).

http://www.campbellfoundation.net/grant-requests

Rising Tide Foundation: Programs in Libertarian, Social/education, and Cancer Funding

- Libertarian topics: leadership development, capacity building and training across a range of issues.

- Social/education topics: projects that promote effective and scalable practices to enhance educational reform.

Funding/duration not specified.

http://www.risingtide-foundation.org/#!grant-programs/c1ugo

U.S. DOD/Defense Threat Reduction Agency: Fundamental Research to Counter Weapons of Mass Destruction (WMD) BAA – White Paper

Topics: WMD sensing and recognition (interactions between materials and various electromagnetic phenomena, molecules, nuclear radiation, and particles); Network sciences (response, resilience, and recovery of physical networks after exposure, rapid discovery, theories and representations for low observable WMD-related radical ideation from social networks); Protection (physical, biological, and engineering sciences to protect personnel, sensitive electronic systems, and structural infrastructure from the effects of WMD); Defeat (improving energetic materials for use against WMD facilities and systems); Securing WMD (handling, transport, control of access, or eliminating WMD components); Cooperative fundamental research to reduce the global threat of WMD in collaboration with a broad range of global research partners; Chemical and Biological Defense.

http://www.dtra.mil/Research/BasicandAppliedScienceDepartment/ResearchFundingOpportunities.aspx

http://www.grants.gov/web/grants/view-opportunity.html?oppId=275322

European Molecular Biology Organization (EMBO) – various opportunities

Short-term fellowships: To advance molecular biology research by helping scientists to visit another laboratory for applying a technique not available in the home laboratory. The fellowships are only provided for exchanges between 2 EMBC member states and are not awarded for exchanges between two laboratories within the same country. The fellowships cover travel plus subsistence of the fellow alone.

http://www.embo.org/funding-awards/fellowships/short-term-fellowships

Young Investigator: supports life scientists who have been group leaders for less than four years at the time of application in setting up their laboratories.

Financial support for networking for four years and benefit from training opportunities, support for their lab members and mentoring.

https://www.embo.org/funding/fellowships-grants-and-career-support/young-investigator-programme/

Travel Grants: travel grants are provided for participants to attend EMBO practical courses, lecture courses, symposia, and other select EMBO events. Covers travel only.

http://www.embo.org/funding-awards/travel-grants

Workshops: present and discuss the latest findings in their subject areas related to the life sciences

https://www.embo.org/funding/funding-for-conferences-and-training/workshops/

Alpha-1 Foundation: Out of-Cycle ***Research grants in Alpha-1 Antitrypsin (AAT) Deficiency

Purpose: to support large, typically clinical grants that do not fit into the in-cycle grant program. The investigator should contact the Foundation before considering applying for an out-of-cycle application.

https://alpha1.org/grant-opportunities/

Beyond Batten Disease Foundation – rolling acceptance of LOIs

BBDF is interested in novel targets and therapeutic approaches for juvenile Batten disease. Areas of interest are outlined at agency web site. Procedure is to submit a Letter of Intent (LOI) that provides a preliminary overview of the project, resource, or conference. Awards vary between $5,000 up to $2-million, with an average academic grant of $150,000 over two years.

https://beyondbatten.org/research/about-funding/

Immune Tolerance Network (ITN): Clinical Trials and Assays & Biomarkers in diseases of the immune system - Concept Proposals

ITN is a non-profit, government-funded consortium of researchers working together to establish new treatments for diseases of the immune system. The ITN conducts clinical trials of specialized immune tolerance therapies in the following areas:

* prevention of organ transplant rejection (in liver, kidney and islet transplantation)

* treatment of autoimmune diseases (such as type 1 diabetes, multiple sclerosis, lupus and others)

* prevention and treatment of allergies and asthma

Clinical Trials: ITN accepts applications for novel clinical trials, in the areas of:

Islet Transplantation

Kidney & Liver Transplantation

Autoimmune Diseases

Allergy & Asthma

Assays & Biomarkers: ITN accepts applications for the development of novel tolerance assay or mechanistic studies, for the purposes of establishing new surrogate markers of immune tolerance and investigating the mechanisms of clinical tolerance.

** ITN does NOT accept proposals for non-human or preclinical studies.

www.immunetolerance.org/professionals/proposals/guidelines

Jeffrey Modell Foundation:

*Specific Immune Defect Research Program -Goal: to support the study of mechanisms and presentation of specific defects of the immune system, leading to a better understanding of the conditions and their impact on overall health outcomes.

*Children Immune deficiency project – Goal: to alleviate disease, seek cures, and improve the quality of life of children affected with Primary Immunodeficiency.

Funding: up to $25K / yr for up to 2 years.

(Applications accepted on a rolling basis) Note: please contact Research Authority if planning to submit - overhead not covered

http://www.jmfworld.com/medical/research-grants/research-grants-1

Thrasher Research Fund: Pediatric Research

Supports medical research aimed to improve children's health in a variety of significant pediatric problems, with an emphasis on projects that have the potential to translate into clinically meaningful results within a few years. Both incidence and severity are considered when determining the significance of the proposed topic. Funding: the median award amount is $300K over 3 years.

https://www.thrasherresearch.org/SitePages/al-thrasher-award.aspx

Coalition to Cure Calpain 3: Research Grant

(Contact Research Authority if planning to submit- overhead)

Support for research for enabling further translational development that can lead to meaningful therapeutic approaches for limb-girdle muscular dystrophy, type 2A/calpainopathy (LGMD2A). In support of this goal C3 funds projects that are likely to expand the understanding of calpain 3 and LGMD2A disease.

http://www.curecalpain3.org/research/

Action Duchenne: Research Grants - Pre Preposal

Applications considered throughout the year. The general research strategy is to increase understanding of Duchenne muscular dystrophy and to support research into, among other topics, novel ideas by Duchenne healthcare professionals, Outcome measures and natural history data, multidisciplinary standards of care, across the age spectrum. Range of previously funded projects $30K-$175K.

https://www.actionduchenne.org/how-do-we-choose-research-to-fund

Found Animals Michelson Grants: non-surgical sterilization products or technologies for use in dogs and cats

Found Animals will provide up to $50 million in multiple, multi-year international grants through the Michelson Grants in Reproductive Biology, for promising research in pursuit of non-surgical sterilization products or technologies for use in dogs and cats. The Foundation seeks proposals for up to $250,000 USD per year for up to 3 years of funding.

http://www.michelsonprizeandgrants.org/

Fanconi Anemia Research Fund (FSRF): Research Grants

Funds interdisciplinary & translational research that will lead to rapid discovery & development of therapies or strategies that treat, control, or cure Fanconi anemia (FA).

Priorities:

- (Top priority) To define the pathogenesis of cancers including head & neck & anogenital squamous cell carcinomas that affect persons with FA, and to develop strategies for early detection, prevention, treatment, & cure.

- To understand how alteration of the FA genes and their products lead to the clinical manifestations of the disease.

- To determine the causes of bone marrow failure, myelodysplasia, and leukemia in individuals with FA, and to develop strategies to prevent, treat and cure these disorders.

- To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.

- To support the creation of shared resources, databases, and technologies for the international FA research community.

Funding: $25,000 - $250,000 for 1-2 years

www.fanconi.org/explore/apply-for-grant-funding

The Lymphatic Malformation Institute (LMI)

Focus: advancing the understanding of the lymphatic system and, specifically, of the rare lymphatic malformations, generalized lymphatic anomaly (GLA)/ Lymphangiomatosis and Gorham-Stout disease. Funding for 1 year.

Please Contact the research authority before applying (no overhead)

http://www.lmiresearch.org/funding-model/

National Organization for Rare Disorders (NORD): Research Grants (LOI):

Scientific studies and/or clinical research studies to address below orphaned rare diseases.

-Cat Eye Syndrome – 1 grant of up to $30,000 for scientific and/or clinical research studies

-Malonic Aciduria – 1 grant of up to $50,000 for scientific and/or clinical research studies

-Post-Orgasmic Illness Syndrome –1 grant of up to $31,000 for scientific and/or clinical research studies

https://rarediseases.org/for-clinicians-and-researchers/research-opportunities/requests-proposals/

www.jsmf.org/apply/collaborative/index.htm

Microsoft Azure for Research Award Program – Bi-monthly RFPs

Microsoft Research is soliciting proposals for the use of Microsoft Azure in research. We welcome research proposals from any branch of scholarly activity. We review these proposals on the fifteenth of even-numbered months (April, June, August, and so forth).

http://research.microsoft.com/en-us/projects/azure/default.aspx#award-program

Jain Foundation: Research Grants (Dysferlinopathies)

The explicit goal of the Jain Foundation is to expedite development of a treatment or cure for the dysferlinopathies (LGMD2B and Miyoshi Myopathy).

http://www.jain-foundation.org/scientific-resources/apply-funding#pre-proposals

American Fibromyalgia Syndrome Association (AFSA)

Priority Areas for Research:

Sleep-Related Priorities: to gain a better understanding of the relationship between the neurobiology of sleep in people with FMS and the various symptoms of this condition.
Other Important Priorities: listed in the website.

Funding: Up to $50,000 for 1 Year. )No overhead)

http://www.afsafund.org/grant.htm#priority

Restless legs syndrome (RLS) Foundation: Small research grants

Funding priorities include basic and clinical research to promote a better understanding of the disease, advance new treatments and find a curefor RLS. The Research Grant Program invites innovative approaches, interdisciplinary studies and support of promising postdoctoral candidates. The primary areas of funding have been genetics, epidemiology, iron regulation, neurophysiology and animal models/treatment.

Funding: average award is $35,000 per year. (No overhead)

https://www.rls.org/research-grants/apply-for-a-grant

PCDH19 Alliance: Research Grants

Funds research directly towards understanding the expression of the PCDH19 gene and the function of the PCDH19 protein, finding therapeutic treatments, and a cure for PCDH19 Epilepsy. Funding: between $25,000 -$75,000 for 1 year.

https://www.pcdh19info.org/copy-of-patient-assistance-grant

International foundation for CDKL5 research: IFCR Grant Program (LOI)

Priority areas:

1. Research dedicated to furthering the understanding of CDKL5 function to
inform the development of targeted, novel therapies.

2. Transformative research to enhance our understanding of the cellular,
molecular, genetic and systems-level mechanisms contributing to the
pathogenesis of CDKL5 deficiency disorder, facilitating the continued
investigation of disease-modifying strategies.

3. Development of high-throughput techniques (and relevant animal/cellular
models) to assess the potential efficacy of therapeutic interventions against
phenotypic deficits of CDKL5 deficiency disorder.

4. Translational and clinical research that will facilitate elevated understanding
of the natural history of CDKL5 deficiency disorder as it relates to symptom
progression (including but not limited to seizures and cognitive delay),
pharmacosensitivity, and response to behavioral/supportive therapies.

https://www.cdkl5.com/research/request-for-proposals/

Diamond Blackfan Anemia Foundation: Research Grant

Aim: developing a clearer understanding of Diamond Blackfan Anemia (DBA) and finding the best therapy and, ultimately, a cure for this disorder.

https://dbafoundation.org/our-research/

https://dbafoundation.org/research/grant-proposal-forms/

Shire (Medical Research): Investigator Initiated Research (IIR)

Shire provides IIR grants with the intention of improving medical and scientific knowledge through the generation of new or confirmatory scientific and/or clinical information.

IIR study designs supported by an IIR grant may include but are not limited to:

· Epidemiological, preclinical (in vitro or in vivo animal) or clinical investigations

· Interventional or observational

· Prospective, cross-sectional or retrospective

Link to Areas of Interest

https://www.shire.com/research-and-development/investigator-initiated-research/areas-of-interest

Bayer: Center of Expertise in Tropical Agriculture (CEAT)

CEAT Latin America welcomes collaborations on novel approaches relating to sustainable crop farming in tropical environments. Aiming to enable technologies, approaches and services from ideas to marketed products in order to anticipate trends and support farmers’ decision-making in tropical agriculture. The research can be related to (but not limited to) resistance monitoring (weeds, pests and diseases), future threats to tropical agriculture (new pests), digital farming, automatic / online systems for pest monitoring, integrated disease, weed, and insect management/control, combined seeds and crop protection strategies and improved crops for higher yields. This program is open to application on a rolling basis. Funding limit and program duration is Discretionary.

https://innovate.bayer.com/programs/ceat-center-expertise-tropical-agriculture#application-process